Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Imlunestrant
Generic name : Inluriyo
Manufactured By : Eli Lilly
Indications : ER+ HER2- ve ESR1-advanced breast cancer
Medicine Description : A targeted oral therapy for ER-positive, HER2-negative advanced breast cancer, Imlunestrant (Inluriyo) is a next-generation selective estrogen receptor degrader (SERD) that blocks and degrades estrogen receptors, including tumors with ESR1 mutations, to slow cancer progression. It is used in patients whose disease has progressed after prior endocrine therapy. Taken orally, it helps improve progression-free survival. Common side effects include nausea, fatigue, hot flashes, and joint pain. Regular monitoring is recommended to manage treatment-related adverse effects and overall tolerability.